Glaukos (GKOS) Non-Current Assets (2014 - 2026)
Glaukos' (GKOS) quarterly Non-Current Assets came in at $407.6 million in Q1 2026, down 21.87% year-on-year from $521.6 million in Q1 2025, and down 2.61% on a QoQ basis from $418.5 million in Q4 2025.
Glaukos (GKOS) Non-Current Assets (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Non-Current Assets data on file, last reported at $407.6 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 21.87% year-over-year to $407.6 million in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 9.01% decrease from a year earlier, with the FY2025 full-year figure at $418.5 million, down 20.28% from the prior year.
- Non-Current Assets for Q1 2026 stood at $407.6 million, down from $418.5 million in the prior quarter.
- Over the last five years, Non-Current Assets for GKOS reached as high as $560.9 million in Q1 2022 and fell as low as $407.6 million in Q1 2026.
- Historically, Non-Current Assets has averaged $530.8 million across 5 years, with a median of $545.0 million in 2023.
- Across the five-year window, Non-Current Assets grew 2.9% in 2025 and dropped 21.87% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $558.5 million in 2022, then retreated by 2.43% to $545.0 million in 2023, then retreated by 3.67% to $525.0 million in 2024, then retreated by 20.28% to $418.5 million in 2025, then retreated by 2.61% to $407.6 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $407.6 million in Q1 2026, $418.5 million in Q4 2025, and $544.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 407.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 407.57 Mn |
| Dec 31, 2025 | 418.50 Mn |
| Sep 30, 2025 | 544.61 Mn |
| Jun 30, 2025 | 550.89 Mn |
| Mar 31, 2025 | 521.63 Mn |
| Dec 31, 2024 | 524.96 Mn |
| Sep 30, 2024 | 529.26 Mn |
| Jun 30, 2024 | 535.89 Mn |
| Mar 31, 2024 | 544.73 Mn |
| Dec 31, 2023 | 544.95 Mn |
| Sep 30, 2023 | 549.11 Mn |
| Jun 30, 2023 | 555.48 Mn |
| Mar 31, 2023 | 556.71 Mn |
| Dec 31, 2022 | 558.52 Mn |
| Sep 30, 2022 | 559.63 Mn |
| Jun 30, 2022 | 560.18 Mn |
| Mar 31, 2022 | 560.87 Mn |
| Dec 31, 2021 | 563.57 Mn |
| Sep 30, 2021 | 562.32 Mn |
| Jun 30, 2021 | 553.19 Mn |